PLAUR and neoplasm: Taken together, these results showed that ATF24 modification increased the tumor-specific delivery of ATF24-PEG-Lipo in vivo, likely resulting from the reduced drug flow back to circulation via an interaction between ATF24 in the liposomes and the uPAR expressed on the cell surface56.